People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | — | Other Health Care | Series B | $72.7M | $376.6M | 2013 |
Daniel A. Janney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel A. Janney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick G. Enright | 1 | 7 |
| Louis G. Lange | 1 | 4 |
| Timothy M. Mayleben | 1 | 4 |
| Nicole S. Vitullo | 1 | 2 |
| Dov A. Goldstein | 1 | 2 |
| Tim M. Mayleben | 1 | 2 |
| Alison S. Kiley | 1 | 1 |
| Dov S. Goldstein | 1 | 1 |
| Alison S. De Bord | 1 | 1 |
| Noah L. Rosenberg | 1 | 1 |
| Troy A. Ignelzi | 1 | 1 |
| Nicole G. Vitullo | 1 | 1 |
| Roger S. Newton | 1 | 1 |
| Louis M. Lange | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.